FDA has approved the Pfizer vaccine on an emergency basis. The agency said the approval of the Pfizer-Bio-Tech vaccine

Albert Bourla, CEO chief executive of US pharmaceutical giant Pfizer, was faced with a series of tough questions about the efficacy